By Daniel Beaird
How BayCare Health System’s Shaneka Demps and her value analysis teams drive clinical integration across the organization.

Shaneka Demps leans on her infection prevention credentials and clinical background in everything she does at BayCare Health System, a provider that operates 16 hospitals across Florida.
“Suppliers have come to us in the past and said, ‘This ink pen will save you from infections. Spend double or triple the cost for this item. It’s going to help you,’” she explained.
Back then, BayCare’s supply chain team didn’t have clinicians on board to look at the science, ingredients or how the product was made and if it truly would improve outcomes.
“That’s how I got into supply chain in the first place,” said Demps, manager of the value analysis department for BayCare.
Her responsibility is to create, facilitate and manage the value analysis process systemwide. The supply chain team and value analysis committee meet monthly with BayCare’s infection prevention director to share which products are being requested, what the outcomes are and the peer-reviewed literature that supports or disputes them.
“I’m certainly not the expert, but we just know how important it is to all the products that we touch,” Demps said. “Our clinical experiences all lead to a wide range of critical thinking and innovative solutions.”
Balancing act
Demps still holds an IP certification, and with many years of infection prevention experience, she focuses on patient outcomes while reviewing cost and quality. She thinks about how a product portfolio change or addition impacts the quality of BayCare’s patient care and experiences.
“That’s been truly beneficial, specifically my critical care experience in pediatrics and cardiology, when speaking to surgeons about the products they need, or don’t need, when working on the delicate populations we serve,” she explained.
The clinically integrated value analysis committee at BayCare drives standardization and improved outcomes through research-driven product selection. Financial stewardship, quality and compassionate patient care, and community health are their driving guidelines through clinical engagement, vertical integration and true clinical collaboration.
Demps says clinical preference can be a challenge when working with physicians who want what they feel is best to use for patient care. But it really comes down to the product improving patient outcomes. Many times, it is necessary to host peer dialogue so that the clinicians can speak to their counterparts to review outcomes and the perceived product benefits in order to provide a consensus on recommending or considering a physician preferred item.
“The product could be nice and shiny, but does it allow for a better experience for the patient?” Demps asks. “We drive the conversation to explore if the product provides enough benefit to add cost to the patient’s case and that’s a balancing act.”

Successful decision making and implementation
BayCare analyzes the complete cost of their decision making. That’s everything from soft costs like avoiding health care-associated infections (HAIs), decreasing OR time and improving efficiencies to hard costs like deploying new products or processes, coupled with additional code or applicable reimbursement.
Peer-reviewed literature and cost and comparative benchmarking play major roles.
“We should receive competitive pricing based on our model, size and commitment,” Demps said. “We understand there are times when we need to use products to improve our ability to provide care, but the cost increase cannot impede our ability to provide affordable care to our community.”
One of the most successful value analysis projects BayCare implemented was the internalization of spinal bracing for the organization. They now stock one supplier’s braces in their consolidated service center instead of ordering cervical collars, lumbosacral orthosis (LSO) and thoraco-lumbosacral orthosis (TLSO), or back braces, from outside OEM manufacturers. This allows for earlier ambulation and decreased length of stay for patients.
Prior to the change, patients were waiting for the brace to be delivered to the hospital, which could take two days or more after measurements.
“That was time the patient was clear to ambulate with physical therapy but couldn’t since they were waiting for the appropriate brace,” Demps said. “Now the PT or RN grabs the brace from the supply room and assists the patient with early mobilization after spine surgery. In addition to cost savings, this is a better outcome for our Neuroscience Institute patients.”
Clinical stakeholders make passionate projects
These successful product decisions are made with the help of BayCare’s clinicians and their involvement in the value analysis process. Each value analysis committee has clinical stakeholders that provide vital information on current practices, best case scenarios and challenges to the status quo. Clinicians vote on each decision and actively evaluate products, providing objective and measurable information on the experience and outcomes.
Demps’ team includes many clinicians, and they are always listening in committee meetings. Specifically, when BayCare’s environmental services (EVS) committee meets, they’re always tuned in to keywords.
“We’re always infusing ourselves into their conversation because clinicians want to do the right thing for the environment, but they might not know what to do with the information,” she said. “If I hear, ‘We’re wasting the product a ton and I don’t think it’s right,’ I know my team can figure out how to avoid that waste in the future.”
Demps is excited about a BayCare passion project this year. Patients and the EVS committee have expressed dissatisfaction with seeing new and never-opened items like the deodorant and hair comb provided by the hospital being thrown in the trash. So, BayCare is giving patients a simple card to choose what they would like to receive in their care package and what they would use. This is a more consistent method to help curb waste.
“We’re even developing a tool to capture unused items and donate them to local missions,” she said. “It is truly my warm and fuzzy project of the year.”
Challenges local and abroad
BayCare knows the challenges of getting supplies when natural disasters hit, or unforeseen circumstances upset the day-to-day of patient care. The Florida health system is familiar with the threat of hurricanes like Helene and Milton last year and they’re still talking about IV solution supplies.
“We make sure we have a certain amount of supply in our warehouse,” Demps said. “Not everyone is fortunate enough to have a CSC, but we do, and our inventory logistics team is amazing.”
Demps says BayCare monitors what’s going on in the communities it serves and what’s at risk. They also monitor where their products come from and if there is something on the horizon that could disrupt operations.
“We learned during the pandemic that we should really know where our suppliers get our product from,” she said. “Is it from Puerto Rico where a hurricane could hit? Is it from China where tariffs could take effect? Is there going to be a strike at a port?”
BayCare tries to have enough stock in its warehouse but also acts quickly when an oncoming issue is in the way of product. Demps’ background helped BayCare avoid product that wasn’t protective during the pandemic. She could look at the specs and determine if the barrier for care was met or not.
“I was really keyed in on what the suppliers were trying to bring in,” she said. “A lot of sites were frantic because they had used something that wasn’t protective. But if it didn’t meet our specifications, we didn’t use it.”
Present and future adaptations
A lot of things were learned. All new product, equipment or service opportunities at BayCare Health System today must be reviewed with BayCare Purchasing Partners (BPP), BayCare’s Group Purchasing Organization and value analysis prior to adoption or approved usage of the new item/opportunity at any of its sites. BayCare encourages vendors to discuss opportunities with BPP prior to engaging clinicians for interest and support. “We take this opportunity to head off creating a ground swell of clinician support for something that we cannot implement due to existing contractual obligations,” Demps said. “Our role is a simple review of the existing obligations and informing the vendor whether they are clear to begin clinical discussions. If interested, a clinical champion will begin the official request process for VAT submission. Our clinically integrated value analysis teams must review and approve all opportunities for cost impact, operational improvement, quality improvement, waste reduction etc.”
But providers and suppliers are still learning. Demps hopes for a better way to organize and categorize data across all providers for better data management, substitutions and categorization. She says that while the United Nations Standard Products and Services Code (UNSPSC) helps, most GPOs and suppliers have their own versions of approved categorization.
And with the onset of artificial intelligence, Demps can see a future where value analysis innovations adopt AI models to input the requested service, product or project and run it through various intricacies in a provider’s system while factoring in expected outcomes and peer-reviewed literature to apply a score of adoption.
“That’s in my head,” she said. “But it is the future.”
